Aera Therapeutics CSO Hire: Fuel Your Genetic Med Pipeline

🚀 Battle Card: Aera Therapeutics

• Bill Querbes, Ph.D., Chief Scientific Officer · 🔗 LinkedIn

• This Aera Therapeutics sales trigger signals a strategic push to accelerate genetic medicine delivery platforms. → Source

• Scaling lipid & protein nanoparticle R&D across multiple modalities

• Coordinating cross-functional teams from discovery through clinics

• Primary: End-to-end LNP formulation services → Accelerate lead optimization & scale-up

• Expansion: Collaborative R&D informatics platform → Boost data visibility and team handoffs

• HQ: Boston, MA

• Employees: ≈ 80

• Rev: ≈ $1 M

• Website: https://www.aeratx.com

🤼 Competitive Intel

Product/Engineering

• Benchling — R&D Data Platform
• Unique edge: Unified lab data & workflows
• Evaluated by CSO for streamlined discovery-to-development.

• Precision NanoSystems — LNP Formulation Systems
• Unique edge: Scalable microfluidic equipment
• Evaluated by VP Ops for flexible scale-up.

• Merck MilliporeSigma — Lipid Nanoparticle Reagents
• Unique edge: GMP-grade lipid libraries
• Evaluated by Head of Process Dev for supply reliability.

• Veeva Systems — QMS & Regulatory Software
• Unique edge: Cloud compliance for life sciences
• Evaluated by Quality Director for audit readiness.

HR & People

• Workday — HRIS & Finance
• Unique edge: Unified HR & finance ops
• Evaluated by HR VP for scaling headcount.

• Greenhouse — Recruiting Software
• Unique edge: Structured interview workflows
• Evaluated by Talent Leader for hire velocity.

• Lever — Applicant Tracking
• Unique edge: Collaborative hiring pipelines
• Evaluated by HR Manager for candidate experience.

• BambooHR — Core HR Platform
• Unique edge: Employee self-service
• Evaluated by People Ops for onboarding efficiency.

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑end-to-end LNP formulation services❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Bill
COMPANY     = Aera Therapeutics
DEPT        = R&D
SIZE        = ≈40
BOTTLENECK  = scaling lipid & protein nanoparticle R&D across multiple modalities
EVENT       = appointment of a new CSO
DETAIL      = his appointment as Chief Scientific Officer
PAIN        = coordinating cross-functional teams from discovery through clinical trials
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250901702274&div=41152219
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈100
EMP_EST     = ≈80
REV_EST     = ≈$1M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈40-person R&D

Bill—noticed your R&D team is ≈40.

That’s when scaling lipid & protein nanoparticle R&D across multiple modalities slows growth.

We helped ≈ TBD fix this with end-to-end LNP formulation services.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈100.

DM ≤45 words, TONE:
Saw your post about his appointment as Chief Scientific Officer — coordinating cross-functional teams from discovery through clinical trials.  
end-to-end LNP formulation services. ≈ TBD.  
Quick chat?